New insights into ovarian cancer pathology. (Q53143668)

11 May 2018

title

New insights into ovarian cancer pathology. (English)

1 reference

11 May 2018

0 references

1 reference

J Prat

1

1 reference

11 May 2018

publication date

1 September 2012

1 reference

11 May 2018

published in

Annals of Oncology

1 reference

11 May 2018

volume

23 Suppl 10

1 reference

11 May 2018

page(s)

x111-7

1 reference

11 May 2018

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Serous carcinogenesis in the fallopian tube: a descriptive classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

The genesis and evolution of high-grade serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Genetic analysis of the early natural history of epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Low-grade serous carcinomas of the ovary contain very few point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

A distinct molecular profile associated with mucinous epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Histologic transformation of benign endometriosis to early epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS300

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS300

1 reference

11 May 2018

1 reference

11 May 2018